Authors:
SENNITT MV
KAUMANN AJ
MOLENAAR P
BEELEY LJ
YOUNG PW
KELLY J
CHAPMAN H
HENSON SM
BERGE JM
DEAN DK
KOTECHA NR
MORGAN HKA
RAMI HK
WARD RW
THOMPSON M
WILSON S
SMITH SA
CAWTHORNE MA
STOCK MJ
ARCH JRS
Citation: Mv. Sennitt et al., THE CONTRIBUTION OF CLASSICAL (BETA(1 2)-) AND ATYPICAL BETA-ADRENOCEPTORS TO THE STIMULATION OF HUMAN WHITE ADIPOCYTE LIPOLYSIS AND RIGHT ATRIAL APPENDAGE CONTRACTION BY NOVEL BETA(3)-ADRENOCEPTOR AGONISTS OFDIFFERING SELECTIVITIES/, The Journal of pharmacology and experimental therapeutics, 285(3), 1998, pp. 1084-1095
Authors:
PALLETT AL
EMILSSON V
COY D
TAYLOR J
WOON CW
CAWTHORNE MA
Citation: Al. Pallett et al., EXPRESSION OF MULTIPLE SOMATOSTATIN RECEPTOR SUBTYPES IN ZUCKER RAT ISLETS AND FUNCTIONAL TYPING OF THE SOMATOSTATIN INDUCED-INHIBITION OF INSULIN-SECRETION, Diabetologia, 41, 1998, pp. 592-592
Authors:
SMITH SA
BOAM D
CAWTHORNE MA
SIDAWAY J
NEWMAN M
WILKINSON M
DUNMORE S
LISTER CA
Citation: Sa. Smith et al., ROSIGLITAZONE REDUCES OVEREXPRESSION OF INSULIN AND AMYLIN MESSENGER-RNA IN HYPERTROPHIED PANCREATIC-ISLETS, Diabetologia, 41, 1998, pp. 659-659
Authors:
LISTER CA
BOAM D
BRETHERTONWATT D
CAWTHORNE MA
MOORE G
LOUGHBOROUGH S
WARRACK J
WILKINSON M
SMITH SA
Citation: Ca. Lister et al., ROSIGLITAZONE INCREASES PANCREATIC-ISLET AREA, NUMBER AND INSULIN CONTENT, BUT NOT INSULIN GENE-EXPRESSION, Diabetologia, 41, 1998, pp. 660-660
Authors:
SMITH S
BOAM D
BRETHERTONWATT D
CAWTHORNE MA
MOORE G
LOUGHBOROUGH S
WARRACK J
WILKINSON M
LIS C
Citation: S. Smith et al., ROSIGLITAZONE INCREASES PANCREATIC-ISLET AREA, DENSITY AND INSULIN CONTENT, BUT NOT INSULIN GENE-EXPRESSION, Diabetes, 47, 1998, pp. 72-72
Authors:
SMITH S
BOAM D
CAWTHORNE MA
SIDAWAY J
NEWMAN M
WILKINSON M
DUNMORE S
LISTER C
Citation: S. Smith et al., ROSIGLITAZONE IMPROVES INSULIN SENSITIVITY AND REDUCES HYPEREXPRESSION OF INSULIN AND AMYLIN MESSENGER-RNAS IN PANCREATIC-ISLETS, Diabetes, 47, 1998, pp. 365-365
Authors:
LIU YL
SENNITT MV
HISLOP DC
CROMBIE DL
HEYMAN RA
CAWTHORNE MA
Citation: Yl. Liu et al., REXINOID-X RECEPTOR AGONISTS IMPROVE INSULIN SENSITIVITY AND HAVE ANTIOBESITY EFFECTS IN ZUCKER FA FA RATS/, Diabetes, 47, 1998, pp. 1099-1099
Authors:
EMILSSON V
SUMMERS RJ
HAMILTON S
LIU YL
CAWTHORNE MA
Citation: V. Emilsson et al., THE EFFECTS OF THE BETA(3)-ADRENOCEPTOR AGONIST BRL-35135 ON UCP ISOFORM MESSENGER-RNA EXPRESSION, Biochemical and biophysical research communications (Print), 252(2), 1998, pp. 450-454
Citation: Yl. Liu et al., LEPTIN INHIBITS GLYCOGEN-SYNTHESIS IN THE ISOLATED SOLEUS MUSCLE OF OBESE (OB OB) MICE/, FEBS letters, 411(2-3), 1997, pp. 351-355
Authors:
EMILSSON V
LIU YL
CAWTHORNE MA
MORTON NM
DAVENPORT M
Citation: V. Emilsson et al., EXPRESSION OF THE FUNCTIONAL LEPTIN RECEPTOR MESSENGER-RNA IN PANCREATIC-ISLETS AND DIRECT INHIBITORY-ACTION OF LEPTIN ON INSULIN-SECRETION, Diabetes, 46(2), 1997, pp. 313-316
Authors:
PALLETT AL
MORTON NM
CAWTHORNE MA
EMILSSON V
Citation: Al. Pallett et al., LEPTIN INHIBITS INSULIN-SECRETION AND REDUCES INSULIN MESSENGER-RNA LEVELS IN RAT ISOLATED PANCREATIC-ISLETS, Biochemical and biophysical research communications, 238(1), 1997, pp. 267-270
Authors:
ORIOWO MA
CHAPMAN H
KIRKHAM DM
SENNITT MV
RUFFOLO RR
CAWTHORNE MA
Citation: Ma. Oriowo et al., THE SELECTIVITY IN-VITRO OF THE STEREOISOMERS OF THE BETA-3 ADRENOCEPTOR AGONIST BRL-37344, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 22-27
Citation: M. Davenport et al., INCREASED EXPRESSION OF SOMATOSTATIN SUBTYPE 2 MESSENGER-RNA IN KIDNEY ZUCKER (FA FA) RATS/, Diabetes, 45, 1996, pp. 490-490
Authors:
DENG CJ
PAOLONIGIACOBINO A
KUEHNE F
BOSS O
REVELLI JP
MOINAT M
CAWTHORNE MA
MUZZIN P
GIACOBINO JP
Citation: Cj. Deng et al., RESPECTIVE DEGREE OF EXPRESSION OF BETA(1)-ADRENOCEPTOR, BETA(2)-ADRENOCEPTOR AND BETA(3)-ADRENOCEPTOR IN HUMAN BROWN AND WHITE ADIPOSE TISSUES, British Journal of Pharmacology, 118(4), 1996, pp. 929-934
Citation: Yl. Liu et al., BIPHASIC EFFECTS OF THE BETA-ADRENOCEPTOR AGONIST, BRL-37344, ON GLUCOSE-UTILIZATION IN RAT ISOLATED SKELETAL-MUSCLE, British Journal of Pharmacology, 117(6), 1996, pp. 1355-1361
Authors:
PEARSON SL
CAWTHORNE MA
CLAPHAM JC
DUNMORE SJ
HOLMES SD
MOORE GBT
SMITH SA
TADAYYON M
Citation: Sl. Pearson et al., THE THIAZOLIDINEDIONE INSULIN SENSITIZER, BRL-49653, INCREASES THE EXPRESSION OF PPAR-GAMMA AND AP(2) IN ADIPOSE-TISSUE OF HIGH-FAT-FED RATS, Biochemical and biophysical research communications, 229(3), 1996, pp. 752-757
Authors:
KLAUS S
MUZZIN P
REVELLI JP
CAWTHORNE MA
GIACOBINO JP
RICQUIER D
Citation: S. Klaus et al., CONTROL OF BETA(3)-ADRENERGIC RECEPTOR GENE-EXPRESSION IN BROWN ADIPOCYTES IN CULTURE, Molecular and cellular endocrinology, 109(2), 1995, pp. 189-195
Citation: M. Davenport et al., CHANGES IN PLASMA BETA-CELL TROPIN CONCENTRATIONS DURING PREGNANCY INRATS, Journal of Endocrinology, 146(1), 1995, pp. 177-182
Authors:
ELDERSHAW TPD
RATTIGAN S
CAWTHORNE MA
BUCKINGHAM RE
COLQUHOUN EQ
CLARK MG
Citation: Tpd. Eldershaw et al., TREATMENT WITH THE THIAZOLIDINEDIONE (BRL-49653) DECREASES INSULIN-RESISTANCE IN OBESE ZUCKER HINDLIMB, Hormone and Metabolic Research, 27(4), 1995, pp. 169-172
Authors:
DAVENPORT M
CHEUNG N
DUNMORE SJ
COY DH
CAWTHORNE MA
Citation: M. Davenport et al., SOMATOSTATIN TYPE-5 RECEPTORS MEDIATE THE INHIBITORY-ACTION OF SOMATOSTATIN ON INSULIN-SECRETION IN ZUCKER FATTY RAT PERFUSED PANCREAS, Diabetologia, 38, 1995, pp. 106-106